ConductScience.org, home

Paper23001043

MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.

Yang S and 9 others. Oncogene, 2013. Cited by 191 papers, by iCite.

Cite this record

ConductScience Library. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Papers, record 23001043. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23001043

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
PubMed
Journal
Oncogene
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
191
iCite
Relative citation ratio, by iCite
5.58
iCite
Revised in PubMed
2026-10-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang SS
2Li YY
3Gao JJ
4Zhang TT
5Li SS
6Luo AA
7Chen HH
8Ding FF
9Wang XX
10Liu ZZ

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
MicroRNAsMajor topic
Proto-Oncogene Proteins c-fosMajor topic
3' Untranslated Regions
Animals
Base Pairing
Base Sequence
Cell Line, Tumor
Cell Movement
Female
Gene Expression
Gene Expression Regulation, Neoplastic
Humans
Lymphatic Metastasis
Mice
Neoplasm Invasiveness
Neoplasm Metastasis
Fos-Related Antigen 1

Source PubMed

Download CSV of topics

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121240262The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.Nat Med2011https://conductscience.org/library/papers/21240262PubMed
219461653The miR-34 family in cancer and apoptosis.Cell Death Differ2010https://conductscience.org/library/papers/19461653PubMed
318948893MicroRNA-10b and breast cancer metastasis.Nature2008https://conductscience.org/library/papers/18948893PubMed
414973191Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/14973191PubMed
522074923MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells.J Biol Chem2012https://conductscience.org/library/papers/22074923PubMed
621692045miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.Cancer2011https://conductscience.org/library/papers/21692045PubMed
722020437miR-34 miRNAs provide a barrier for somatic cell reprogramming.Nat Cell Biol2011https://conductscience.org/library/papers/22020437PubMed
819524507A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.Cell2009https://conductscience.org/library/papers/19524507PubMed
920736365Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis.Cancer Res2010https://conductscience.org/library/papers/20736365PubMed
1010451706Deletion mapping of chromosomal region 1p32-pter in primary breast cancer.Genes Chromosomes Cancer1999https://conductscience.org/library/papers/10451706PubMed
1121831840Wild-type p53 controls cell motility and invasion by dual regulation of MET expression.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21831840PubMed
1211431356Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.Cancer Res2001https://conductscience.org/library/papers/11431356PubMed
1317898713Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.Nature2007https://conductscience.org/library/papers/17898713PubMed
1421814748Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.Breast Cancer Res Treat2011https://conductscience.org/library/papers/21814748PubMed
1522085528miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro.Chin J Cancer2011https://conductscience.org/library/papers/22085528PubMed
1619262572MicroRNAs--the micro steering wheel of tumour metastases.Nat Rev Cancer2009https://conductscience.org/library/papers/19262572PubMed
1718406353Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.FEBS Lett2008https://conductscience.org/library/papers/18406353PubMed
1818519671Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.Cancer Res2008https://conductscience.org/library/papers/18519671PubMed
1912778135The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.Nat Rev Cancer2003https://conductscience.org/library/papers/12778135PubMed
2010502734Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype.Int J Cancer1999https://conductscience.org/library/papers/10502734PubMed

See all 67 referencesDownload CSV of references

Cited by136

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.

PMIDTitleJournalYearIn PapersSource
42967165Unraveling the EMT Spectrum in Aggressive Breast Cancer: Bridging Molecular Hybrid States with Functional Assay Interpretation.Onco Targets Ther2026https://conductscience.org/library/papers/42967165PubMed
42882513Aberrant Transcription-Factor Expression and Regulatory microRNAs in Metastatic Breast Cancer.Cells2026https://conductscience.org/library/papers/42882513PubMed
41059335FRA1 (FOSL1) suppresses neoplastic transformation and modulates radiation responses via transcriptional control of mitogenic and stress-responsive networks.Front Cell Dev Biol2025https://conductscience.org/library/papers/41059335PubMed
40144339Suppression of endometriosis by miRNA-34a via inhibition of matrix metalloproteinase-2: An alternative pathway to impede invasion.Noncoding RNA Res2025https://conductscience.org/library/papers/40144339PubMed
39795985Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.Int J Mol Sci2024https://conductscience.org/library/papers/39795985PubMed
39006295Clinical implications of serum miR-34a in breast cancer and its predictive value for the efficacy of neoadjuvant chemotherapy.Am J Transl Res2024https://conductscience.org/library/papers/39006295PubMed
38802812Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy.J Nanobiotechnology2024https://conductscience.org/library/papers/38802812PubMed
38791400FOSL1's Oncogene Roles in Glioma/Glioma Stem Cells and Tumorigenesis: A Comprehensive Review.Int J Mol Sci2024https://conductscience.org/library/papers/38791400PubMed
38616694Bioinformatics Study and Experimental Evaluation of miR-182, and miR-34 Expression Profiles in Tuberculosis and Lung Cancer.Tuberc Respir Dis (Seoul)2024https://conductscience.org/library/papers/38616694PubMed
38303867MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathway.J Dent Sci2024https://conductscience.org/library/papers/38303867PubMed
37965449Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development.Front Oncol2023https://conductscience.org/library/papers/37965449PubMed
37962808Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein.Cell Oncol (Dordr)2024https://conductscience.org/library/papers/37962808PubMed
37835417MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential.Cancers (Basel)2023https://conductscience.org/library/papers/37835417PubMed
37833709Intelligent identification system of gastric stromal tumors based on blood biopsy indicators.BMC Med Inform Decis Mak2023https://conductscience.org/library/papers/37833709PubMed
37686617Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors.Cancers (Basel)2023https://conductscience.org/library/papers/37686617PubMed
37259089EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?Mol Cancer2023https://conductscience.org/library/papers/37259089PubMed
37176013FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer.Int J Mol Sci2023https://conductscience.org/library/papers/37176013PubMed
37083075Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer.Int J Oncol2023https://conductscience.org/library/papers/37083075PubMed
36032067The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases.Front Immunol2022https://conductscience.org/library/papers/36032067PubMed
35961977A miR-34a-guided, tRNAiMet-derived, piR_019752-like fragment (tRiMetF31) suppresses migration and angiogenesis of breast cancer cells via targeting PFKFB3.Cell Death Discov2022https://conductscience.org/library/papers/35961977PubMed

See all 136 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FOSL18061PubTator's text mininghttps://conductscience.org/library/genes/8061NCBI Gene
MIR34A407040PubTator's text mininghttps://conductscience.org/library/genes/407040NCBI Gene
MIR34C407042PubTator's text mininghttps://conductscience.org/library/genes/407042NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23001043

GET https://conductscience.org/api/papers/v1/23001043/references?page=2